Boston Trust Walden Corp Astrazeneca PLC Transaction History
Boston Trust Walden Corp
- $14 Billion
- Q4 2024
A detailed history of Boston Trust Walden Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Boston Trust Walden Corp holds 5,471 shares of AZN stock, worth $412,513. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,471
Previous 6,166
11.27%
Holding current value
$412,513
Previous $480,000
25.42%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.55 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.09 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.83 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.79 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.81 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...